Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
$11.32
+0.5%
$11.31
$10.43
$12.90
$100.75M-0.014,036 shs343 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.09
-7.0%
$0.14
$0.00
$0.24
$26.49M2.4894,150 shs103,373 shs
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
$11.95
$11.46
$9.95
$14.47
$97.48M0.36238,297 shsN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.80
-0.6%
$0.77
$0.44
$3.87
$98.84M0.781.01 million shs370,210 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
0.00%-0.18%-0.52%+0.85%+8.39%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-5.53%+6.45%-37.34%-42.64%-47.87%
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
0.00%0.00%+8.83%+5.75%+13.16%
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
+2.27%+2.92%+26.90%-27.68%+51.19%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
$11.32
+0.5%
$11.31
$10.43
$12.90
$100.75M-0.014,036 shs343 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.09
-7.0%
$0.14
$0.00
$0.24
$26.49M2.4894,150 shs103,373 shs
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
$11.95
$11.46
$9.95
$14.47
$97.48M0.36238,297 shsN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$0.80
-0.6%
$0.77
$0.44
$3.87
$98.84M0.781.01 million shs370,210 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
0.00%-0.18%-0.52%+0.85%+8.39%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-5.53%+6.45%-37.34%-42.64%-47.87%
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
0.00%0.00%+8.83%+5.75%+13.16%
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
+2.27%+2.92%+26.90%-27.68%+51.19%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
2.00
HoldN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.00
N/AN/AN/A
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
1.00
SellN/AN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
2.60
Moderate Buy$8.75996.63% Upside

Current Analyst Ratings Breakdown

Latest ETST, DTSQ, PCSC, and RANI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/20/2026
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
UpgradeSell (D)Sell (D+)
7/17/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
DowngradeSell (D-)Sell (E+)
7/13/2026
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
UpgradeSell (D+)Hold (C-)
6/29/2026
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
Reiterated RatingSell (D+)
6/24/2026
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
Reiterated RatingSell (D)
6/24/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
Reiterated RatingSell (D-)
5/20/2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
Reiterated RatingBuy$5.00
(Data available from 8/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/AN/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$35.70M0.74$0.01 per share7.80$0.02 per share4.61
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
N/AN/A$0.09 per share127.23($0.77) per shareN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
$1.63M60.64N/AN/A$0.34 per share2.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$3.63MN/AN/A9.21N/A10.76%64.76%45.11%8/14/2026 (Estimated)
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
$840K-$0.06N/AN/AN/AN/A-2.70%-0.84%N/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
-$29.67M-$0.41N/AN/AN/AN/A-206.46%-83.95%8/13/2026 (Estimated)

Latest ETST, DTSQ, PCSC, and RANI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
-$0.05-$0.04+$0.01-$0.04$0.93 million$1.71 million
8/3/2026Q2 2026
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/A$0.0630N/A$0.0630N/AN/A
7/15/2026Q2 2026
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
N/A-$0.01N/A-$0.01N/AN/A
6/18/2026Q4 2026
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.01$0.01N/AN/A$8.91 million$9.50 million
5/15/2026Q1 2026
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
-$0.06-$0.04+$0.02-$0.04$1.13 million$1.71 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
N/AN/AN/AN/AN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/A
1.93
1.58
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
N/A
0.20
0.20
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
N/A
3.40
3.40
CompanyEmployeesShares OutstandingFree FloatOptionable
DT Cloud Star Acquisition Corporation stock logo
DTSQ
DT Cloud Star Acquisition
N/A8.90 million4.19 millionN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
3287.59 million148.17 millionNot Optionable
Perceptive Capital Solutions Corp. stock logo
PCSC
Perceptive Capital Solutions
N/A8.16 million6.36 millionN/A
Rani Therapeutics Holdings, Inc. stock logo
RANI
Rani Therapeutics
110123.88 million90.77 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

DT Cloud Star Acquisition stock logo

DT Cloud Star Acquisition NASDAQ:DTSQ

$11.32 +0.06 (+0.53%)
Closing price 03:57 PM Eastern
Extended Trading
$11.32 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DT Cloud Star Acquisition Corporation focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2022 and is based in Brooklyn, New York.

Earth Science Tech stock logo

Earth Science Tech OTCMKTS:ETST

$0.09 -0.01 (-6.97%)
As of 03:35 PM Eastern

Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.

Perceptive Capital Solutions stock logo

Perceptive Capital Solutions NASDAQ:PCSC

$11.95 0.00 (0.00%)
As of 07/21/2026

Perceptive Capital Solutions Corp is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Perceptive Capital Solutions Corp is based in NEW YORK.

Rani Therapeutics stock logo

Rani Therapeutics NASDAQ:RANI

$0.80 0.00 (-0.61%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 +0.01 (+1.39%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.